J. Vijai

发表

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

Jane E. Carpenter, Jaana M. Hartikainen, Sandra L. Halverson, 2015, JNCI Journal of the National Cancer Institute.

Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.

Kenneth Offit, Barry S Taylor, Vignesh Ravichandran, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

W. Chung, P. Hall, V. Pankratz, 2013, PLoS genetics.

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

Kristen S Purrington, Jack A. Taylor, A. Whittemore, 2018, American Journal of Human Genetics.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jaana M. Hartikainen, W. Chung, 2019, Nature Genetics.

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Yurii B. Shvetsov, Simon G. Coetzee, A. Whittemore, 2015, Nature Genetics.

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Lara E Sucheston-Campbell, Simon G. Coetzee, Lara E. Sucheston-Campbell, 2017, Nature Genetics.

Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.

Raymond M. Moore, F. Couch, K. Offit, 2016, American journal of human genetics.

Sequencing an Ashkenazi reference panel supports population-targeted personal genomics and illuminates Jewish and European origins

Kenneth Offit, Diether Lambrechts, Gil Atzmon, 2014, Nature Communications.

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

Discovery of common and rare genetic risk variants for colorectal cancer

Mathieu Lemire, Steven Gallinger, Michael Wainberg, 2018, Nature Genetics.

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

Ahmet Zehir, Levi Garraway, Colin C Pritchard, 2016, The New England journal of medicine.

Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations

L. Kiemeney, P. Fasching, R. Vierkant, 2020, bioRxiv.

Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes

Jack A. Taylor, W. Chung, S. Cross, 2019, bioRxiv.

Inherited variants at 3q13.33 and 3p24.1 are associated with risk of diffuse large B-cell lymphoma and implicate immune pathways.

J. Cerhan, G. Salles, Y. Asmann, 2019, Human molecular genetics.

Major vault protein (MVP) gene polymorphisms and drug resistance in mesial temporal lobe epilepsy with hippocampal sclerosis.

J. Vijai, K. Radhakrishnan, M. Banerjee, 2013, Gene.

Towards Automation of Germline Variant Curation in Clinical Cancer Genetics

Zarina Shameer, Kenneth Offit, Mark Robson, 2019, Genetics in Medicine.

A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.

M. Daly, F. Couch, G. Rennert, 2016, Cancer discovery.

Novel ultra-rare exonic variants identified in a founder population implicate cadherins in schizophrenia

Max W. Y. Lam, Judy H. Cho, H. Ostrer, 2020, Neuron.

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

Paolo Vineis, Peter Kraft, Lucia Miligi, 2015, Nature Communications.

Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study

J. Cerhan, N. Camp, G. Salles, 2020, Cancer Epidemiology, Biomarkers & Prevention.

Genetic Variation in DNA Repair Pathways and Risk of Non-Hodgkin's Lymphoma

C. Sander, B. Reva, Yevgeniy Antipin, 2014, PloS one.

An analysis of the association between prostate cancer risk loci, PSA levels, disease aggressiveness and disease-specific mortality

P. Scardino, J. Eastham, K. Offit, 2015, British Journal of Cancer.

Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations

Annette Lee, W. Chung, R. Nussbaum, 2018, Human mutation.

Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk

D. Altshuler, P. Fasching, P. Hall, 2013, PLoS genetics.

Inherited TP53 Variants and Risk of Prostate Cancer.

R. Nussbaum, E. V. Van Allen, K. Offit, 2021, European urology.

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

W. Chung, P. Hall, V. Pankratz, 2013, PLoS Genetics.

Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

M. Daly, D. Altshuler, F. Couch, 2010, PLoS Genetics.

Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer

K. Offit, J. Vijai, M. Robson, 2012, Cancer.

A Recurrent ERCC 3 Truncating Mutation Confers Moderate Risk for Breast Cancer

M. Daly, F. Couch, G. Rennert, 2016 .

Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

Patrick Neven, Hui Zhao, Nazneen Rahman, 2012, PloS one.

Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

Daniel J. Park, S. Cross, M. Beckmann, 2012, PLoS ONE.

Genome-wide Association Study Identiﬁes Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

Jian Gu, Paolo Vineis, Theodore R Holford, 2022 .

Male breast cancer in BRCA1 and BRCA2 mutation carriers

R. Nussbaum, D. Steinemann, F. Couch, 2018 .

Rare de novo germline copy-number variation in testicular cancer.

B. Yamrom, J. Kendall, A. Leotta, 2012, American journal of human genetics.

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

J. Cerhan, G. Colditz, E. Ziv, 2022, Leukemia.

Genome-wide association study identifies multiple susceptibility loci for diffuse large B-cell lymphoma

Paolo Vineis, Theodore R Holford, Peter Kraft, 2014, Nature Genetics.

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes.

Paolo Vineis, Theodore R Holford, Peter Kraft, 2016, Human molecular genetics.

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170

Nicholas A. Sinnott-Armstrong, Richard C. Sallari, S. Cross, 2016, Nature Genetics.

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

Paolo Vineis, Theodore R Holford, Peter Kraft, 2016, Nature Communications.

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

Steven N. Hart, Chunling Hu, Mark E. Robson, 2017, npj Breast Cancer.

Frequency of actionable cancer predisposing germline mutations in patients with lung cancers.

David R. Jones, B. Taylor, M. Berger, 2018 .

Variants at IRX4 as prostate cancer expression quantitative trait loci

M. Rubin, K. Offit, R. Klein, 2013, European Journal of Human Genetics.

Cancer genomics and inherited risk.

K. Offit, J. Vijai, M. Robson, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry.

Zhaoming, Jack A. Taylor, L. Kiemeney, 2016, Human molecular genetics.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

W. Chung, R. Nussbaum, F. Couch, 2017, Journal of the National Cancer Institute.

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A. Whittemore, L. Kiemeney, S. Cross, 2016, Nature Communications.

Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

D. Steinemann, F. Couch, B. Bonanni, 2016, PloS one.

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

R. Nussbaum, D. Steinemann, F. Couch, 2016, Breast Cancer Research.

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

R. Nussbaum, D. Steinemann, V. Pankratz, 2014, Breast Cancer Research.

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

J. S. Hoffman, W. Chung, V. Pankratz, 2012, Human mutation.

Genetic architecture of prostate cancer in the Ashkenazi Jewish population

W. Foulkes, K. Offit, R. Klein, 2011, British Journal of Cancer.

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma

Z. Szallasi, I. Csabai, G. Klus, 2023, bioRxiv.

Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry

Jane E. Carpenter, Jack A. Taylor, M. Beckmann, 2023, Genome Medicine.

The context-specific role of germline pathogenicity in tumorigenesis

B. Taylor, N. Schultz, M. Ladanyi, 2021, Nature Genetics.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2019, Nature Genetics.

Integrative Clinical Genomics of Metastatic Cancer

Robert J. Lonigro, Daniel F. Hayes, Arul M. Chinnaiyan, 2017, Nature.

Susceptibility Loci Associated with Prostate Cancer Progression and Mortality

P. Scardino, J. Eastham, K. Offit, 2010, Clinical Cancer Research.

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.

D. Weisenburger, J. Cerhan, M. Carrington, 2018, Cancer research.

Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer

B. Taylor, M. Berger, C. Rudin, 2020, Clinical Cancer Research.

University of Groningen Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Couch,

F. Couch, B. Bonanni, O. Olopade, 2013 .

Germline ETV6 Mutations Confer Susceptibility to Acute Lymphoblastic Leukemia and Thrombocytopenia

Michael N. Edmonson, J. Downing, C. Pui, 2015, PLoS genetics.

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

M. Daly, D. Altshuler, F. Couch, 2010, PLoS genetics.

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms

M. Berger, C. Iacobuzio-Donahue, S. Leach, 2018, Journal of the National Cancer Institute.

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk

Raymond M. Moore, F. Couch, B. Bonanni, 2017, npj Breast Cancer.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

J. Cerhan, C. Mayr, N. Rothman, 2018, Nature Communications.

Genome-wide association studies of cancer predisposition.

Peter R. Thom, K. Offit, T. Kirchhoff, 2010, Hematology/oncology clinics of North America.

The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt

E. Kandel, J. Vijai, J. Kichina, 2009, Oncogene.

Novel Common Genetic Susceptibility Loci for Colorectal Cancer

Stephanie A. Bien, Elizabeth L. Barry, Aung Ko Win, 2018, Journal of the National Cancer Institute.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types.

Jian Su, Wen Tan, Paolo Vineis, 2015, Journal of the National Cancer Institute.

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

Alison P. Klein, William Wheeler, Li Jin, 2015 .

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

Joshua M. Korn, M. Daly, D. Altshuler, 2011, Human Genetics.

Susceptibility Loci Associated with Specific and Shared Subtypes of Lymphoid Malignancies

A. Viale, A. Zelenetz, K. Offit, 2013, PLoS genetics.

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.

Ahmet Zehir, Kenneth Offit, Barry S Taylor, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia

Rohini Rau-Murthy, Jinghui Zhang, Kenneth Offit, 2013, Nature Genetics.

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

N. Schultz, M. Ladanyi, M. Berger, 2021, Nature Cancer.

Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores

F. Couch, O. Olopade, J. Benítez, 2021, Journal of the National Cancer Institute.

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.

K. Offit, I. Ostrovnaya, E. Plimack, 2016, Clinical Genitourinary Cancer.

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

D. Steinemann, F. Couch, O. Olopade, 2017, Journal of Clinical Oncology.

Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma

M. Ladanyi, K. Offit, R. Motzer, 2018, JAMA oncology.

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

Jane E. Carpenter, Jack A. Taylor, W. Chung, 2021, Nature Communications.

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Sandra L. Halverson, A. Whittemore, L. Kiemeney, 2016, Gynecologic oncology.

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: the role of the host.

K. Offit, I. Ostrovnaya, G. Iyer, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Lara E Sucheston-Campbell, Simon G. Coetzee, Dennis J. Hazelett, 2017, Nature Genetics.

Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

W. Chung, V. Pankratz, F. Couch, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations

V. Seshan, M. Ladanyi, M. Berger, 2021, Cancer Epidemiology, Biomarkers & Prevention.

FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor.

Eliseos J. Mucaki, F. Couch, B. Bonanni, 2015, Human molecular genetics.

A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

W. Chung, V. Pankratz, F. Couch, 2012, Cancer Epidemiology, Biomarkers & Prevention.

Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer

Joshua M. Korn, Debra, M. Daly, 2010, PLoS genetics.

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.

F. Couch, B. Karlan, J. Benítez, 2011, Journal of the National Cancer Institute.

Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases.

Donavan T. Cheng, M. Ladanyi, M. Berger, 2015 .

Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening

K. Offit, S. Lipkin, J. Vijai, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 Variant.

D. Altshuler, W. Foulkes, C. Hudis, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

Jane E. Carpenter, A. Whittemore, S. Cross, 2016, Breast Cancer Research.

Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements

S. Raychaudhuri, K. Offit, R. Klein, 2015, bioRxiv.

Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170

Wei Zheng, Mads Thomassen, Nicholas A. Sinnott-Armstrong, 2016 .

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

W. Chung, R. Nussbaum, D. Steinemann, 2015, Breast Cancer Research.

Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

W. Chung, R. Nussbaum, D. Steinemann, 2015, PloS one.

Title Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA 1 and BRCA 2 mutation carriers

R. Nussbaum, D. Steinemann, V. Pankratz, 2015 .

phylogenetic approach identified mitochondrial haplogroup T 1 a 1 as inversely associated with breast cancer risk in BRCA 2 mutation carriers

W. Chung, D. Steinemann, V. Pankratz, 2015 .

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Olufunmilayo I. Olopade, Mads Thomassen, Torben A. Kruse, 2014, PLoS genetics.

Genetic susceptibility to diffuse large B‐cell lymphoma in a pooled study of three Eastern Asian populations

J. Cerhan, N. Rothman, S. Chanock, 2015, European journal of haematology.

Assessment of SLX4 Mutations in Hereditary Breast Cancers

K. Offit, I. Ostrovnaya, T. Kirchhoff, 2013, PloS one.

Two truncating variants in FANCC and breast cancer risk

Jane E. Carpenter, M. Beckmann, P. Fasching, 2019, Scientific Reports.

P. Gaffney, J. Cerhan, T. Molina, 2017, Lupus Science & Medicine.

Mendelian randomisation study of smoking exposure in relation to breast cancer risk

Jack A. Taylor, S. Cross, M. Beckmann, 2021, British Journal of Cancer.

Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes

N. Camp, C. Vachon, K. Offit, 2021, Human molecular genetics.

Germline SDHA mutations in children and adults with cancer

Ed Reznik, Alex Kentsis, Kenneth Offit, 2018, Cold Spring Harbor molecular case studies.

Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder .

K. Offit, I. Ostrovnaya, D. Bajorin, 2017, International journal of clinical pharmacology and therapeutics.

A locus for juvenile myoclonic epilepsy maps to 2q33–q36

Joseph Vijai, J. Vijai, R. Ratnapriya, 2010, Human Genetics.

Absence ofGABRA1 Ala322Asp mutation in juvenile myoclonic epilepsy families from India

P. Satishchandra, J. Vijai, K. Radhakrishnan, 2003, Journal of Genetics.

Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands

J. Vijai, P. Cherian, K. Radhakrishnan, 2003, Seizure.

Genetically Determined Height and Risk of Non-hodgkin Lymphoma

J. Cerhan, N. Camp, T. Molina, 2020, Frontiers in Oncology.

Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition

O. Olopade, K. Offit, D. Pruss, 2022, JCO precision oncology.

Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes

J. Cerhan, M. Carrington, N. Camp, 2021, Journal of translational genetics and genomics.

Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary Cancers.

F. Couch, B. Bonanni, K. Offit, 2020, JCO precision oncology.

Genetic overlap between autoimmune diseases and non‐Hodgkin lymphoma subtypes

J. Cerhan, N. Camp, G. Salles, 2019, Genetic epidemiology.

Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort.

N. Schultz, M. Ladanyi, M. Berger, 2022, Cancer discovery.

Cancer predisposing germline mutations in patients (pts) with urothelial cancer (UC) of the renal pelvis (R-P), ureter (U) and bladder (B).

K. Offit, A. Hakimi, J. Coleman, 2017 .

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer.

B. Taylor, M. Ladanyi, M. Berger, 2022, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Genetic association analysis of KCNQ3 and juvenile myoclonic epilepsy in a South Indian population

J. Vijai, P. Cherian, K. Radhakrishnan, 2003, Human Genetics.

Discovery of common and rare genetic risk variants for colorectal cancer

Stephanie A. Bien, Aung Ko Win, Sarah C. Nelson, 2018, Nature Genetics.

Genetic association analysis of KCNQ3 and juvenile myoclonic epilepsy

J. Vijai, P. Cherian, K. Radhakrishnan, 2003 .

Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

S. Rosset, W. He, S. Cross, 2023, Journal of Medical Genetics.

Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes

Steven N. Hart, Robert J. Klein, Vignesh Ravichandran, 2016, Briefings Bioinform..

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

Paolo Vineis, Peter Kraft, Bin Zhu, 2018, Nature Communications.